How The Current Investment Landscape Is Stifling Rare Disease Development

One in ten people suffer from rare diseases in the United States. There is a big need for therapeutic advancement for the rare disease community and, oftentimes, treatments for these diseases are the patient’s last hope. However, there is a crisis happening today in rare disease. The current public markets are stifling innovation and drug development for rare diseases. This webinar will examine the current markets, their effect on the innovation in rare disease drug development, and what we can do to help.

Key Points To Be Discussed:

• Learn about the current state of investments for the rare disease sector
• Understand the market’s effect on innovation in rare disease
• Hear from leading experts on what we do as a community to help drive innovation forward